CTOs on the Move

CI Web Group

www.ciwebgroup.com

 
CI Web Group is a full-service marketing agency specializing in web design, website development, SEO, social media marketing, local business listing management, mobile app development, graphics design, and business strategy.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Spark Unlimited

Spark Unlimited is one of the leading providers in Software and Internet. It is based in Sherman Oaks, CA. To find more information about Spark Unlimited, please visit www.sparkunlimited.com.

Tictail

Tictail is a global community that allows you to discover the world`s greatest independent brands. We`re a free-to-use, DIY e-commerce platform that enables small business owners to set up an online store in minutes, and is also a destination for discerning shoppers looking to discover their new favorite brands from around the world. Tictail focuses on strong community integration, simplicity of use, mobile-first technology, and attractive, customizable design. Tictail`s shoppable marketplace showcases over 100,000 independent brands from 150 countries worldwide. Founded in 2012, Tictail has offices in New York and Stockholm.

TheraSim

TheraSim, Inc is a Durham, NC-based company in the Software and Internet sector.

Smiley Technologies

We are Bankings Strategic Partner. Fully customizable technology solutions that deliver more up-time and real-time access to data for you and your customers.

Immunome

Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.